Integrated Care Pathways: Pioneering specialised integrated healthcare

Integrated care pathways represent a systematic approach to patient care in specialised medical fields. We have been at the forefront of developing these pathways, particularly in the areas of lung, prostate, and breast cancer. They serve as clinical blueprints, guiding our clinics in delivering comprehensive, efficient, and high-quality care in specialised fields.

Delivering World-Class Lung Cancer Screening & Care Pathway Across Affidea

Lung cancer, a leading cause of cancer-related deaths globally, is primarily linked to tobacco smoke, with up to 87% of cases attributed to it. The economic and health impacts of lung cancer are immense, highlighting the need for effective screening and early detection.

 Affidea's Thoracic Imaging Subspecialty Team has developed a Low Dose CT Screening program aligned with international guidelines. This program is pivotal in detecting early-stage lung tumours. The low-dose spiral CT scan, a key component of this program, is notable for its low radiation (1-1.3 mSv) and high accuracy in diagnosing small pulmonary nodules. This method significantly enhances the chances of treating lung cancer in its initial stages. Studies, including the Nelson Trial, underscore the efficacy of low-dose spiral CT in reducing mortality rates in high-risk individuals. This method's effectiveness in early detection makes it a cornerstone of lung cancer care.

 The management of suspected lung cancer cases requires a multidisciplinary team, including radiologists, thoracic surgeons, oncologists, pathologists, and other specialists. This collaborative approach ensures comprehensive patient care, from diagnosis to treatment.

World-Class Prostate Care Pathway

Prostate cancer, one of the most common cancers worldwide, requires a diverse range of healthcare services. Affidea's prostate cancer care pathway is designed to integrate these services seamlessly.

This pathway encompasses various aspects of prostate cancer management, including:

• Medical consultations
• Laboratory testing
• Advanced imaging (MRI, ultrasound, CT, Bone scan, PET)
• Prostate biopsy
• Active surveillance
• Treatment options (surgery, radiotherapy, medical therapy)

The pathway is structured to assist healthcare providers at all levels in implementing and expanding world-class prostate cancer care services. This holistic approach is tailored to meet the specific needs and market opportunities in different regions.

World-Class Breast Care Pathway

The Breast Care Pathway at Affidea represents a comprehensive approach to managing breast cancer, one of the most common cancers affecting women globally. This pathway is designed to offer a full spectrum of services, leveraging the latest medical technology and a multidisciplinary team approach to ensure the best possible outcomes for patients.

Key Features of the Breast Care Pathway

• Early Detection and Screening: Utilizing advanced imaging techniques such as mammography, ultrasound, and MRI, the pathway prioritises early detection of breast cancer, which is crucial for successful treatment.
• Diagnostic Precision: Biopsies, when necessary, are conducted using minimally invasive techniques guided by the latest imaging methods, ensuring accuracy and patient comfort.
• Personalised Treatment Plans: Each patient's treatment plan is tailored to their specific condition, considering factors like the cancer stage, the patient's overall health, and personal preferences. This may include surgery, chemotherapy, radiotherapy, or a combination of these treatments.
• Research and Innovation: Affidea is committed to integrating the latest research and innovations into their care pathway, ensuring patients can access cutting-edge treatments and therapies.

The Breast Care Pathway at Affidea is not just about treating cancer but about offering a holistic care experience. It aims to improve survival rates, enhance the quality of life for patients, and reduce the physical and emotional burden of breast cancer treatment. By providing coordinated and efficient care, the pathway also seeks to set a benchmark for breast cancer management globally.

Dr Alessandro Roncacci, SVP Chief Medical Officer at Affidea, stated: “Through our integrated care pathways in lung, prostate, and breast cancer, we aim to provide a seamless, multidisciplinary approach that not only addresses the medical needs of our patients but also supports their overall well-being. We believe in leveraging cutting-edge technology and innovative solutions, expert medical knowledge, and compassionate care to ensure every patient receives the best possible support. The care pathways that we, at Affidea, designed include not only the clinical approach but also the operational and commercial ones, looking to the business development. Our goal is to set a new standard in specialised healthcare, transforming the lives of our patients and advancing the future of medicine."